Lack of IL-27 signaling was shown to decrease the survival and double the incidence of osteosarcoma, possibly due to increased stability of the mutant p53 protein expression, indicating that IL-27 signaling negatively modulates the oncogenic properties of mutant p53 in vivo (47). The gene discussed is TP53; the disease is osteosarcoma.